Single drug dose can prevent early bone loss in HIV patients
The researchers assessed 343 individuals for eligibility, and 63 were selected and randomised to receive either ART and placebo, or ART and zoledronic acid.
Feb 24, 2016, 12:18 PM IST
Bon loss